367 related articles for article (PubMed ID: 17624289)
1. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
Demetri GD; Benjamin RS; Blanke CD; Blay JY; Casali P; Choi H; Corless CL; Debiec-Rychter M; DeMatteo RP; Ettinger DS; Fisher GA; Fletcher CD; Gronchi A; Hohenberger P; Hughes M; Joensuu H; Judson I; Le Cesne A; Maki RG; Morse M; Pappo AS; Pisters PW; Raut CP; Reichardt P; Tyler DS; Van den Abbeele AD; von Mehren M; Wayne JD; Zalcberg J;
J Natl Compr Canc Netw; 2007 Jul; 5 Suppl 2():S1-29; quiz S30. PubMed ID: 17624289
[TBL] [Abstract][Full Text] [Related]
2. NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.
Demetri GD; Benjamin R; Blanke CD; Choi H; Corless C; DeMatteo RP; Eisenberg BL; Fletcher CD; Maki RG; Rubin BP; Van den Abbeele AD; von Mehren M;
J Natl Compr Canc Netw; 2004 May; 2 Suppl 1():S-1-26; quiz 27-30. PubMed ID: 23573667
[TBL] [Abstract][Full Text] [Related]
3. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.
Demetri GD; von Mehren M; Antonescu CR; DeMatteo RP; Ganjoo KN; Maki RG; Pisters PW; Raut CP; Riedel RF; Schuetze S; Sundar HM; Trent JC; Wayne JD
J Natl Compr Canc Netw; 2010 Apr; 8 Suppl 2(0 2):S1-41; quiz S42-4. PubMed ID: 20457867
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumors, version 2.2014.
von Mehren M; Randall RL; Benjamin RS; Boles S; Bui MM; Casper ES; Conrad EU; DeLaney TF; Ganjoo KN; George S; Gonzalez RJ; Heslin MJ; Kane JM; Mayerson J; McGarry SV; Meyer C; O'Donnell RJ; Pappo AS; Paz IB; Pfeifer JD; Riedel RF; Schuetze S; Schupak KD; Schwartz HS; Van Tine BA; Wayne JD; Bergman MA; Sundar H
J Natl Compr Canc Netw; 2014 Jun; 12(6):853-62. PubMed ID: 24925196
[TBL] [Abstract][Full Text] [Related]
5. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.
Blay JY; Bonvalot S; Casali P; Choi H; Debiec-Richter M; Dei Tos AP; Emile JF; Gronchi A; Hogendoorn PC; Joensuu H; Le Cesne A; McClure J; Maurel J; Nupponen N; Ray-Coquard I; Reichardt P; Sciot R; Stroobants S; van Glabbeke M; van Oosterom A; Demetri GD;
Ann Oncol; 2005 Apr; 16(4):566-78. PubMed ID: 15781488
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib for imatinib-resistant GIST.
Joensuu H
Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
[No Abstract] [Full Text] [Related]
7. A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices.
Pisters PWT; Blanke CD; von Mehren M; Picus J; Sirulnik A; Stealey E; Trent JC;
Ann Oncol; 2011 Nov; 22(11):2523-2529. PubMed ID: 21464155
[TBL] [Abstract][Full Text] [Related]
8. Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
Goodman VL; Rock EP; Dagher R; Ramchandani RP; Abraham S; Gobburu JV; Booth BP; Verbois SL; Morse DE; Liang CY; Chidambaram N; Jiang JX; Tang S; Mahjoob K; Justice R; Pazdur R
Clin Cancer Res; 2007 Mar; 13(5):1367-73. PubMed ID: 17332278
[TBL] [Abstract][Full Text] [Related]
9. Management of gastrointestinal stromal tumors.
Hueman MT; Schulick RD
Surg Clin North Am; 2008 Jun; 88(3):599-614, vii. PubMed ID: 18514701
[TBL] [Abstract][Full Text] [Related]
10. [Clinical guidelines for the management of gastrointestinal stromal tumors].
Lopez M; Comandone A; Adamo V; Apice G; Bearzi I; Bracci R; Carlini M; Carpano S; Condorelli S; Covello R; Cucchiara G; Di Filippo F; Doglietto GB; Ficorella C; Garofalo A; Gebbia N; Giuliani F; Massidda B; Messerini L; Palmirotta R; Tonelli F; Vidiri A
Clin Ter; 2006; 157(3):283-99. PubMed ID: 16900856
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathobiology of gastrointestinal stromal sarcomas.
Corless CL; Heinrich MC
Annu Rev Pathol; 2008; 3():557-86. PubMed ID: 18039140
[TBL] [Abstract][Full Text] [Related]
12. New strategies for treating GIST when imatinib fails.
Boyar MS; Taub RN
Cancer Invest; 2007 Aug; 25(5):328-35. PubMed ID: 17661208
[TBL] [Abstract][Full Text] [Related]
13. The role of KIT in the management of patients with gastrointestinal stromal tumors.
Hornick JL; Fletcher CD
Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
[TBL] [Abstract][Full Text] [Related]
14. [Consensus on the medical treatment of gastrointestinal stromal tumors].
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):875-7. PubMed ID: 18396652
[No Abstract] [Full Text] [Related]
15. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib.
Schindler CG; Armbrust T; Gunawan B; Langer C; Füzesi L; Ramadori G
Z Gastroenterol; 2005 Mar; 43(3):267-73. PubMed ID: 15765299
[TBL] [Abstract][Full Text] [Related]
16. NCCN Task Force report: gastrointestinal stromal tumor (GIST).
Demetri G; DeMatteo RP
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-25-8. PubMed ID: 23570095
[No Abstract] [Full Text] [Related]
17. Second line therapies for the treatment of gastrointestinal stromal tumor.
Joensuu H
Curr Opin Oncol; 2007 Jul; 19(4):353-8. PubMed ID: 17545799
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology].
Shen L
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):438-9. PubMed ID: 17845753
[No Abstract] [Full Text] [Related]
19. Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.
Blay JY; von Mehren M; Blackstein ME
Cancer; 2010 Nov; 116(22):5126-37. PubMed ID: 20661913
[TBL] [Abstract][Full Text] [Related]
20. Response evaluation of gastrointestinal stromal tumors.
Choi H
Oncologist; 2008; 13 Suppl 2():4-7. PubMed ID: 18434631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
